학술논문
Intracranial Outcomes of De Novo Brain Metastases Treated With Osimertinib Alone in Patients With Newly Diagnosed EGFR-Mutant NSCLC
Document Type
Article
Author
Source
In JTO Clinical and Research Reports December 2023 4(12)
Subject
Language
ISSN
2666-3643